Ivonescimab Monotherapy Reduced the Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC in China
Summit to Initiate HARMONi-7, a Phase III Trial in First-Line PD-L1 High, Advanced NSCLC, in Early 2025 Ivonescimab Is the First Drug to Achieve Clinically Meaningful... Read more.
Coalition Announces Reinsurance Intermediary Coalition Re
Coalition Re to Offer Active Cyber Reinsurance via Two Products Supported by Aspen-led Capacity SAN FRANCISCO–(BUSINESS WIRE)–Coalition, the world’s... Read more.
Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the European Respiratory Society (ERS) Congress 2024
Mean Change From Baseline in Disease Severity Score (DSS) Showed Significant Improvement with Molgramostim Compared with Placebo at Weeks 24 and 48 Responder Analysis... Read more.
Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
Bexicaserin achieved an overall median seizure reduction of 57.7% in countable motor seizures over an approximate 9-month treatment period Favorable safety and tolerability... Read more.
Day 2 of 11th Annual World Patient Safety, Science & Technology Summit Highlights Importance of Collaboration and Advanced Technologies
IRVINE, Calif.–(BUSINESS WIRE)–The second day of the 11th Annual World Patient Safety, Science & Technology Summit, presented by the Patient Safety... Read more.
Aon and Marsh McLennan Call on (Re)insurance Industry to Aid Ukraine’s Resilience
The firms emphasized that the removal of blanket exclusions would catalyze Ukraine’s growth and future reconstruction MONTE CARLO, Monaco–(BUSINESS WIRE)–Aon... Read more.
Boll & Branch’s Most Luxurious Fabric Debuts on the Runway at Prabal Gurung’s NYFW Show
The fashion designer selected the beloved bedding brand’s rarest fabrication for his Spring 2025 ready-to-wear collection at New York Fashion Week. NEW YORK–(BUSINESS... Read more.
ESGR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enstar Group Limited Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enstar Group Limited (NASDAQ: ESGR) to Sixth... Read more.
GigCapital7 Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing September 10, 2024
PALO ALTO, Calif.–(BUSINESS WIRE)–GigCapital7 Corp. (NASDAQ: GIGGU) (the “Company”), a Cayman Islands exempted company, announced today that holders... Read more.
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
BRANFORD, Conn.–(BUSINESS WIRE)–Azitra, Inc. (NYSE American: AZTR), a precision dermatology company announced that it announced today that Travis Whitfill,... Read more.